茵陈汤辨治新生儿急性高胆红素血症的临床观察

Clinical Studies of Capillaris-soup Treatment on Acute Neonatal Hyperbilirubinemia

目的观察茵陈汤治疗新生儿高胆红素血症的临床疗效。方法将120例患儿随机分为实验组和对照组各60例。对照组给予常规方法治疗,实验组在对照组基础上服用茵陈汤。观察两组治疗前后血清总胆红素、直接胆红素以及间接胆红素的水平变化以及临床治疗效果。结果治疗后两组血清总胆红素、直接胆红素以及间接胆红素的水平改善均优于治疗前,且实验组优于对照组(均P<0.05)。治疗后实验组总有效率91.67%优于对照组的75.00%(P<0.05)。结论茵陈汤治疗新生儿高胆红素血症可显著降低血清胆红素的水平,明显提高临床疗效。

Objective： To observe the clinical efficacy of the capillaris-soup treatment on neonatal hyperbiliru- binemia. Methods： from March 2011 to May 2013 in our hospital 120 cases of neonatal hyperbilirubinemia were randomly divided into the experimental and the control groups, 60 patients in each group. The control group were treated with conventional treatment, while the therapy of the experimental group based on that of the control group took capillaris soup. Serum total bilirubin, direct bilirubin and indirect bilirubin levels, and clinical efficacy were compared before and after treatment. Results： Before treatment,the serum total bilirubin, direct bilirubin and in- direct bilirubin levels in both groups had little difference （P〉 0.05）. After treatment, serum total bilirubin, direct bilirubin and indirect bilirubin levels were improved and better than those before treatment. And the data of the experimental group was better than that of the control group （P〈 0.05） with a statistically significance. The total effective rate was 91.7% ,better than that of the control group （75.0%） with a statistically significance （P〈 0.05）. The data of both groups reduced after treatment, and the effect of the observation group was better than that of the control group. The comparison above was statistically significant. Conclusion： Capillaris soup treatment on neonatal hyperbilirubinemia can significantly reduce the levels of serum bilirubin,and significantly improve the clinical efficacy.